A Phase 2 trial of gemcabene in NASH patients

Trial Profile

A Phase 2 trial of gemcabene in NASH patients

Planning
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs Gemcabene (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Acronyms AZURE-1
  • Most Recent Events

    • 25 Sep 2017 According to a Gemphire Therapeutics media release, plans to initiate this trial in the fourth quarter of 2017.
    • 14 Aug 2017 According to a Gemphire Therapeutics media release, top-line results for this study expected in second half of 2018.
    • 16 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top